Omeros presents promising phase I results for PDE7 inhibitor OMS-182399 for addiction Sep. 18, 2019 No Comments
Preclinical characterization of novel mGlu2 receptor PAMs for the treatment of substance abuse Sep. 10, 2019 No Comments
Discovery of a selective OX1 receptor antagonist for substance abuse and dependency Sep. 5, 2019 No Comments
InterveXion reports interim data from phase II study of IXT-m200 for methamphetamine use disorder July 30, 2019 No Comments
PledPharma reports results from POP phase I trial of calmangafodipir for paracetamol overdose July 18, 2019 No Comments
RSS